Key result
Carotid artery stenting has emerged as a minimally invasive alternative to carotid endarterectomy for stroke prevention in patients with carotid disease, though its value remains highly controversial.
Why the study?
Does carotid artery stenting prevent stroke in patients with severe asymptomatic and symptomatic carotid stenoses compared to carotid endarterectomy?
Does carotid artery stenting prevent stroke in patients with severe asymptomatic and symptomatic carotid stenoses compared to carotid endarterectomy?
This review discusses the evolving role and technological advancements of carotid artery stenting as a minimally invasive alternative to carotid endarterectomy for stroke prevention.
CAS should not yet replace CEA in routine practice; leaves open the need for updated RCTs on modern devices.
In patients with carotid disease, the purpose of carotid artery revascularization is stroke prevention. For >50 years, carotid endarterectomy has been considered the standard treatment for severe asymptomatic and symptomatic carotid stenoses. Carotid artery stenting (CAS) has emerged in the last 15 years as minimally invasive alternative to surgery. However, the value of the endovascular approach in the management of carotid disease patients remains highly controversial. The aims of this review are to elucidate the current role of CAS, to describe the major technology advancements in the field, and to speculate about the future of this therapy.
No takes yet. Share an insight, caveat, or question.
Cremonesi et al. (2014) conducted a review in carotid disease. Carotid artery stenting (CAS) vs. carotid endarterectomy was evaluated. Carotid artery stenting has emerged as a minimally invasive alternative to carotid endarterectomy for stroke prevention in patients with carotid disease, though its value remains highly controversial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: